v3.25.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 183,105 $ 36,926
Restricted cash 42 42
Total cash, cash equivalents and restricted cash 183,147 36,968
Short-term investments   94,965
Accounts and other receivables 321 544
Income tax and R&D incentive receivables 557 2,573
Prepaid expenses and other current assets 4,397 2,204
Total current assets 188,422 137,254
Property and equipment, net 364 413
Other assets 1,564 1,639
Total assets 190,350 139,306
Current liabilities:    
Accounts payable 851 211
Accrued expenses and other current liabilities 8,369 10,257
Total current liabilities 9,220 10,468
Term loan, noncurrent 14,332  
Other noncurrent liabilities 5,431 5,330
Total liabilities 28,983 15,798
Commitments and contingencies (Note 10)
Stockholders' equity:    
Common stock, $0.0001 par value; 200,000,000 shares authorized; 85,076,300 and 72,352,701 shares issued and outstanding as of June 30, 2025 and December 31 2024, respectively 9 7
Additional paid-in capital 769,508 689,864
Accumulated deficit (603,111) (561,390)
Accumulated other comprehensive loss, net (5,039) (4,973)
Total stockholders' equity 161,367 123,508
Total liabilities and stockholders' equity $ 190,350 $ 139,306